J Altern Complement Med
August 2018
Editor´s Note: This is the third commentary from the JACM column partnership with the Osher Collaborative for IntegrativeMedicine. These quarterly columns from leaders of the seven prominent academic centers that constitute the Collaborative are meant to stimulate and enliven thinking about the paradigm, practice, and policy to advance integrative health. In this column, two members at the Osher Center for Integrative Medicine in Chicago, Illinois and San Francisco, California, take on a challenge pioneering field face as they move from the Wild West into professional formation.
View Article and Find Full Text PDFThis study investigated the relationship of children's autism symptoms with their toxic metal body burden and red blood cell (RBC) glutathione levels. In children ages 3-8 years, the severity of autism was assessed using four tools: ADOS, PDD-BI, ATEC, and SAS. Toxic metal body burden was assessed by measuring urinary excretion of toxic metals, both before and after oral dimercaptosuccinic acid (DMSA).
View Article and Find Full Text PDFBackground: This study investigated the effects of oral dimercapto succinic acid (DMSA) therapy on the behavioural symptoms of children with autism spectrum disorders (ASD) ages 3-8 years.
Methods: Phase 1 involved 65 children with ASD who received one round of DMSA (3 days). Participants who had high urinary excretion of toxic metals were selected to continue on to phase 2.
Background: This study investigated the effect of oral dimercapto succinic acid (DMSA) therapy for children with autism spectrum disorders ages 3-8 years.
Methods: Phase 1 involved 65 children who received one round of DMSA (3 days). Participants who had high urinary excretion of toxic metals were selected to continue on to phase 2.